InPharmX Inc., DBA University Learning Systems Phone: 1-800-940-5860 Email: info@universitylearning.com
VAPHS
← All on demand pharmacology CE/CME

On demand pharmacology CE/CME

VAPHS 2026 On Demand

FormatSelf-paced onlineRecordedAugust 26, 2026AccessAvailable now
Log in to register

About this course

Learn at your own pace.

16 hour course for va

Educational information

Designed for meaningful, practical learning.

Sessions

Session
Topic 1: Mabology 101: The Clinical Science Behind Monoclonal Antibodies

Wednesday, August 26, 2026

Speaker: Dr. Kelly Jones Credit hours: 2 ACPE UAN: 0741-0000-26-040-H01-P

Learning objectives
  1. Describe the basic pharmacology behind monoclonal antibodies.
  2. List examples of monoclonal antibodies and the conditions they treat.
  3. Discuss how monoclonal antibodies are made.
  4. Discuss the nomenclature behind naming monoclonal antibodies.
  5. Outline in STEPS format (safety, tolerability, efficacy, price, simplicity) several monoclonal antibodies (i.e., Certolizumab, denosumab, new cholesterol medications.)
  6. Discuss the side effects of selected monoclonal antibodies.
  7. Discuss risk factors associated with these new technologies.
  8. List any general patient education.
Topic 2: Antimicrobial Stewardship Update

Wednesday, August 26, 2026

Speaker: Dr. Christopher M. Bland Credit hours: 1 ACPE UAN: 0741-0000-26-041-H01-P

Learning objectives
  1. Describe best practices for prescribing antimicrobials in various patient settings
  2. Discuss recently approved agents as well as notable new indications for previously approved agents.
  3. Describe best practices for assessing and de-labeling patients with self-reported penicillin allergies.
Topic 3: Current Update on GLP-1 Agonists for Obesity and Other Unique Comorbid Conditions

Wednesday, August 26, 2026

Speaker: Dr. Christopher M. Bland Credit hours: 1 ACPE UAN: 0741-0000-26-042-H01-P

Learning objectives
  1. Delineate key characteristics and outcome data of FDA-approved pharmacotherapy incretin options including GLP-1 agonists for obesity
  2. Describe other important comorbid conditions for which incretin therapies may be appropriate
  3. Discuss future options for incretin therapy in obesity management
Topic 4:New Drug Update

Wednesday, August 26, 2026

Speaker: Dr. Christopher M. Bland Credit hours: 1 ACPE UAN: 0741-0000-26-043-H01-P

Learning objectives
  1. Describe new drugs approved in the last 24 months that have the potential to impact clinical practice.
  2. Discuss clinical and practical pearls of each new agent where applicable compared to standard therapies.
  3. Evaluate each agent's efficacy and safety data to best determine its role in therapy.
Topic 5: Update on Adult Immunizations

Wednesday, August 26, 2026

Speaker: Dr. C. Wayne Weart Credit hours: 1 ACPE UAN: 0741-0000-26-044-H06-P

Learning objectives
  1. Schedule Navigation: Apply the latest CDC Adult Immunization Schedule vs. other evidence-based recommendations to determine vaccine needs based on age, health status, and lifestyle.
  2. Risk Assessment: Identify specialized vaccine indications for high-risk populations, including pregnant individuals, immunocompromised patients, and older adults.
  3. Clinical Screening: Implement a systematic screening protocol to check for valid contraindications and precautions before vaccine administration.
  4. Hesitancy Counseling: Use evidence-based communication strategies, such as motivational interviewing, to address patient concerns and reduce vaccine hesitancy.
Topic 6: Parkinson’s Disease and Its Management

Wednesday, August 26, 2026

Speaker: Dr. C. Wayne Weart Credit hours: 2 ACPE UAN: 0741-0000-26-045-H01-P

Learning objectives
  1. Review the pathophysiology of Parkinson’s disease.
  2. Recognize the motor and non-motor signs and symptoms of Parkinson's disease to understand the variability in presentation from person to person
  3. Compare and contrast the use of the available pharmacologic treatment options to meet the ever-changing needs of people with Parkinson's disease as they progress over time.
  4. Describe how to prescribe, monitor and adjust therapies in patients with Parkinson’s disease.
Topic 7: Depression and Opioid Case Reviews

Thursday, August 27, 2026

Speaker: Dr. Reamer L. Bushardt Credit hours: 2 ACPE UAN: 0741-0000-26-046-H08-P

Learning objectives
  1. Clinical Cases. Discuss pharmacologic management options within clinical cases of patients with depression and opioid use.
  2. Apply best practices and guidance to clinical decision making.
Topic 8: Contraception, Emergency Contraception, Medication Abortion, and Menopause: A Pharmacotherapy Update

Thursday, August 27, 2026

Speaker: Dr. Rebecca Stone Credit hours: 2 ACPE UAN: 0741-0000-26-047-H01-P

Learning objectives
  1. Summarize contraceptive updates, including Long Acting Reversible Contraceptives (LARC), and compare all available hormonal methods to support individualized, patient centered counseling.
  2. 2. Explain the clinical interaction between hormonal contraceptives and GLP-1 receptor agonists and describe clinical management strategies.
  3. 3. Discuss current guidance regarding emergency contraception, including available options, mechanism of action, and efficacy.
  4. 4. Outline current guidance on medication abortion, including available regimens and clinical considerations.
  5. 5. Describe the evidence and rationale behind the removal of the boxed warning on menopausal hormone therapy, and select preferred agents for individualized therapy.
  6. 6. Identify non-hormonal options for menopausal symptom management, with emphasis on neurokinin receptor antagonists for vasomotor symptoms.
Topic 9: Clinical Updates in Neuropsychiatric Pharmacotherapy

Thursday, August 27, 2026

Speaker: Dr. Joshua Caballero Credit hours: 2 ACPE UAN: 0741-0000-26-048-H01-P

Learning objectives
  1. Develop evidence-based benzodiazepine tapering strategies for patients receiving long-term benzodiazepine therapy
  2. Apply recent evidence and guideline updates to optimize the use of psychiatric medications in Lewy body dementia
  3. Evaluate the role of newly approved and emerging psychotropic agents in psychiatry and neurology
Topic 10: Cholesterol Lowering Agents Pharmacology and the 2026 Dyslipidemia Guideline

Thursday, August 27, 2026

Speaker: Dr. Kyle Shapcott Credit hours: 2 ACPE UAN: 0741-0000-26-049-H01-P

Learning objectives
  1. Describe the roles and mechanisms of action of pharmacologic agents in the 2026 guideline for the management of dyslipidemia.
  2. Review updates to diagnostic criteria and risk stratification that influence therapeutic selection and monitoring recommendations.
  3. Discuss the difference between the PREVENT risk algorithm and the 2013 Pooled Cohort Equations for estimating primary atherosclerotic cardiovascular disease (ASCVD) risk.
  4. Review updated therapeutic goals for hypercholesterolemia and the prevention of ASCVD.
  5. Identify patient-specific factors that influence management decisions and therapeutic goals.
  6. Select evidence-based pharmacologic and monitoring plans for patients with dyslipidemia, including those at risk for primary and secondary ASCVD events.

Faculty

Portrait of Dr. Kelly Jones, ULS faculty member

Dr. Kelly Jones, PharmD

Board-Certified Pharmacotherapy Specialist

A family-medicine-trained clinical pharmacist with extensive experience translating pharmacotherapy evidence into primary-care practice.

Professional profile ↗
Portrait of Dr. Christopher M. Bland, ULS faculty member

Dr. Christopher M. Bland, PharmD, FCCP

Clinical Professor · University of Georgia College of Pharmacy

A clinical pharmacy educator and co-founder of Southeastern Research Group Endeavor and TeachMePharm, with a focus on practical infectious-disease pharmacotherapy.

Professional profile ↗
Portrait of Dr. C. Wayne Weart, ULS faculty member

Dr. C. Wayne Weart, PharmD, BCPS, FASHP

Professor Emeritus of Family Medicine and Clinical Pharmacy · Medical University of South Carolina

A distinguished clinical pharmacy educator whose teaching connects new-drug evidence, therapeutics, outcomes, and practical family-medicine care.

Professional profile ↗
Portrait of Dr. Reamer L. Bushardt, ULS faculty member

Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA

Provost and Vice President for Academic Affairs · MGH Institute of Health Professions

A professor and practicing primary-care PA whose work spans health-professions education, substance-use-disorder training, and clinical leadership.

Professional profile ↗
Dr. Rebbecca Stone

Dr. Rebecca Stone, Pharm.D., BCPS, BCACP, FCCP

Clinical and Administrative Pharmacy, Athens
Clinical Professor, University of Georgia College of Pharmacy

Portrait of Dr. Joshua Caballero, ULS faculty member

Dr. Joshua Caballero, PharmD, BCPP, FCCP

Associate Professor · University of Georgia College of Pharmacy

A board-certified psychiatric pharmacist with postdoctoral training in psychiatry and pharmacotherapy and extensive experience teaching psychopharmacology.

Professional profile ↗
Dr. Kyle Shapcott

Dr. Kyle Shapcott , PharmD

Clinical Assistant Professor, Division of Outcomes and
Practice Advancement
Department of Pharmacy Practice
University at Buffalo, The State University of New York

Accreditation

Target audience

Pharmacists, Nurse Practitioners, Physicians, Physician Assistants, Nurses

PHARMACISTS

  • University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. 
  • These programs are accredited for all pharmacists.
  • This course provides 16 hours or 1.6 CEUs.
  • Credit for this course expires on August 26, 2029.

NURSES

  • This course provides 16 hours (1.6 CEU)
  • University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
  • University Learning Systems is approved by CE Broker for Florida, Georgia, Arkansas, District of Columbia, Georgia, New Mexico, and West Virginia, Boards of Nursing. 
  • The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.

OTHER PROFESSIONS

  • CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

  • CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). 

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 16 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians

  • Other healthcare professionals should confirm acceptance and reporting requirements with their licensing or certification board

Requirements and reporting

  • University Learning Systems reports pharmacy credit through CPE Monitor using the participant’s eNABPID number and date of birth.
  • University Learning Systems is approved by CE Broker, for pharmacy, medicine and nursing for participating states,  Tracking #50-11357. Participant's state license number is required for reporting.
  • Credit is based on completed evaluations for registered sessions. 
  • Credit is awarded per session; partial session credit is not available, and breaks are excluded.
  • Other eligible participants receive an applicable statement of credit after completing the required documentation.

Review complete ULS accreditation statements →

Course fees

DescriptionPrice
Default 16 Hours$269

Begin today

Ready when you are.

Log in to register